國立虎尾科技大學 |

Immune strategies for gastrointestinal cancer

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Immune strategies for gastrointestinal cancer/ edited by Markus Moehler, Friedrich Foerster.
other author:	Moehler, Markus.
Published:	Cham :Springer International Publishing : : 2023.,
Description:	viii, 296 p. :ill., digital ; : 24 cm.;
Contained By:	Springer Nature eBook
Subject:	Gastrointestinal system - Cancer -
Online resource:	https://doi.org/10.1007/978-3-031-39944-2
ISBN:	9783031399442

Immune strategies for gastrointestinal cancer
Immune strategies for gastrointestinal cancer[electronic resource] /edited by Markus Moehler, Friedrich Foerster. - Cham :Springer International Publishing :2023. - viii, 296 p. :ill., digital ;24 cm. - Cancer immunotherapy,v. 22662-8392 ;. - Cancer immunotherapy ;v. 2..

Part I Role of the Tumor Microenvironment -- An Overview of the Tumor Microenvironment and Response to Immunotherapy in Gastrointestinal Malignancies -- Part II Esophagus -- Approach to Immunotherapy in Oesophageal Cancer -- Perspective on the Immunotherapy of Esophageal Cancer -- Part III Stomach -- Immunotherapy of Gastric Cancer: Focus on Perioperative Strategies -- Stomach: The Standard of Care ± HER2 -- Perspective on the Immunotherapy of Gastric Cancer -- Part IV Colon -- Immunotherapy in dMMR/MSI-H Colon Cancer -- Immunotherapy in the Treatment of Advanced Colorectal Cancer -- Immunotherapy of Rectal Cancer -- Perspective on Immunotherapy of Colon Cancer: Challenges for the Future -- Part V HCC -- Immune Strategies for Gastrointestinal Cancer: HCC -- Immunotherapy in GI Cancers: Hepatocellular Carcinoma: Perspective -- Part VI Biliary Tract -- Immunotherapy of Biliary Tract Cancer -- Perspective on Immunotherapy Use in Biliary Tract Cancer -- Part VII Pancreas -- Immune Landscape of Pancreas Ductal Adenocarcinoma: Current Therapeutic Strategies and Future Perspective -- Perspective on the Immunotherapy of Pancreatic Cancer -- Part VIII Biomarkers for Immunotherapy in Gastrointestinal Cancers -- Biomarkers for Immunotherapy in Gastrointestinal Cancers.

This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers, and discusses its future place in clinical practice. Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients. This book will appeal to a wide readership, including oncologists, health care professionals in general and biomedical scientists.

ISBN: 9783031399442

Standard No.: 10.1007/978-3-031-39944-2doiSubjects--Topical Terms:

1250697
Gastrointestinal system
--Cancer

LC Class. No.: RC280.D5

Dewey Class. No.: 616.9943306

Immune strategies for gastrointestinal cancer
LDR:03376nam a2200337 a 4500 001 1120518
003 DE-He213
005 20231231171806.0
006 m d
007 cr nn 008maaau
008 240612s2023 sz s 0 eng d
020 $a 9783031399442 $q (electronic bk.)
020 $a 9783031399435 $q (paper)
024 7 $a 10.1007/978-3-031-39944-2 $2 doi
035 $a 978-3-031-39944-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.D5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.9943306 $2 23
090 $a RC280.D5 $b I33 2023
245 0 0 $a Immune strategies for gastrointestinal cancer $h [electronic resource] / $c edited by Markus Moehler, Friedrich Foerster.
260 $a Cham : $c 2023. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 296 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer immunotherapy, $x 2662-8392 ; $v v. 2
505 0 $a Part I Role of the Tumor Microenvironment -- An Overview of the Tumor Microenvironment and Response to Immunotherapy in Gastrointestinal Malignancies -- Part II Esophagus -- Approach to Immunotherapy in Oesophageal Cancer -- Perspective on the Immunotherapy of Esophageal Cancer -- Part III Stomach -- Immunotherapy of Gastric Cancer: Focus on Perioperative Strategies -- Stomach: The Standard of Care ± HER2 -- Perspective on the Immunotherapy of Gastric Cancer -- Part IV Colon -- Immunotherapy in dMMR/MSI-H Colon Cancer -- Immunotherapy in the Treatment of Advanced Colorectal Cancer -- Immunotherapy of Rectal Cancer -- Perspective on Immunotherapy of Colon Cancer: Challenges for the Future -- Part V HCC -- Immune Strategies for Gastrointestinal Cancer: HCC -- Immunotherapy in GI Cancers: Hepatocellular Carcinoma: Perspective -- Part VI Biliary Tract -- Immunotherapy of Biliary Tract Cancer -- Perspective on Immunotherapy Use in Biliary Tract Cancer -- Part VII Pancreas -- Immune Landscape of Pancreas Ductal Adenocarcinoma: Current Therapeutic Strategies and Future Perspective -- Perspective on the Immunotherapy of Pancreatic Cancer -- Part VIII Biomarkers for Immunotherapy in Gastrointestinal Cancers -- Biomarkers for Immunotherapy in Gastrointestinal Cancers.
520 $a This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers, and discusses its future place in clinical practice. Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients. This book will appeal to a wide readership, including oncologists, health care professionals in general and biomedical scientists.
650 0 $a Gastrointestinal system $x Cancer $x Immunotherapy. $3 1250697
650 1 4 $a Oncology. $3 593951
650 2 4 $a Immunotherapy. $3 592896
650 2 4 $a Gastroenterology. $3 673684
650 2 4 $a Health Care. $3 1365997
650 2 4 $a Biomedical Research. $3 643481
700 1 $a Moehler, Markus. $3 1435849
700 1 $a Foerster, Friedrich. $3 1435850
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a Cancer immunotherapy ; $v v. 2. $3 1435851
856 4 0 $u https://doi.org/10.1007/978-3-031-39944-2
950 $a Medicine (SpringerNature-11650)